image: The scientists' new cellular assays could assess the presence of prion-like amyloid beta (top row), alpha-synuclein (middle row), or tau proteins (bottom row) in human kidney cells, as indicated by the bright orange spots. This material relates to a paper that appeared in the May 1, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by A. Aoyagi at University of California, San Francisco in San Francisco, CA; and colleagues was titled, "Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain." view more
Credit: A. Aoyagi <i>et al., Science Translational Medicine</i> (2019)